Last Updated: August 10, 2026

Padagis Israel Company Profile

✉ Email this page to a colleague

« Back to Dashboard

What is the competitive landscape for PADAGIS ISRAEL

PADAGIS ISRAEL has eighty-two approved drugs.

There is one tentative approval on PADAGIS ISRAEL drugs.

Summary for Padagis Israel

US Patents:	0
Tradenames:	48
Ingredients:	48
NDAs:	82
Patent Litigation for Padagis Israel:	See patent lawsuits for Padagis Israel
PTAB Cases with Padagis Israel as petitioner:	See PTAB cases with Padagis Israel as petitioner

Drugs and US Patents for Padagis Israel

+ Get email alerts for changes to this table

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Padagis Israel	BRIMONIDINE TARTRATE	brimonidine tartrate	GEL;TOPICAL	209158-001	Sep 23, 2021	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Padagis Israel	BETAMETHASONE VALERATE	betamethasone valerate	AEROSOL, FOAM;TOPICAL	078337-001	Nov 26, 2012	AB	RX	No	No		⤷ Start Trial				⤷ Start Trial
Padagis Israel	CLOBETASOL PROPIONATE	clobetasol propionate	AEROSOL, FOAM;TOPICAL	077763-001	Mar 10, 2008	AB1	RX	No	No		⤷ Start Trial				⤷ Start Trial
Padagis Israel	TERCONAZOLE	terconazole	SUPPOSITORY;VAGINAL	077149-001	Mar 17, 2006	AB	RX	No	Yes		⤷ Start Trial				⤷ Start Trial
Padagis Israel	NYSTATIN AND TRIAMCINOLONE ACETONIDE	nystatin; triamcinolone acetonide	CREAM;TOPICAL	208479-001	Aug 14, 2017	AT	RX	No	No		⤷ Start Trial				⤷ Start Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Paragraph IV (Patent) Challenges for PADAGIS ISRAEL drugs

Drugname	Dosage	Strength	Tradename	Submissiondate
➤ Subscribe	Vaginal Cream	2%	➤ Subscribe	2009-12-23

Similar Applicant Names

Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.